Amendment to Paid-in Capital Increase Decision
한국유니온제약
080720
Signal Score
Historical Avg Return (5d)
+0.38%
Data Coverage
100%n=2330
Risk-adjusted indicator based on 2330 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Event: Paid-in Capital Increase
AI Analysis Summary
UNION KOREA PHARM CO.,Ltd announced an amendment to its Material Fact Report regarding a decision on a paid-in capital increase. While specific figures are not available, a paid-in capital increase typically leads to share dilution, potentially negatively impacting existing shareholder value. The amendment suggests changes to the initial terms of the capital increase.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.